This insider cluster is routine and non-informative. The Bodenhoff sale is a standard cashless exercise pattern (exercise options, sell to cover cost/tax). No C-suite participation and trivial dollar amounts relative to market cap. No trading action warranted. Monitor for any future C-suite open-market sales exceeding 0.1% of market cap, which would carry more signal.
ASND drugs
ASND drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $261.23entry
- T+1 · 2mo ago +0.87%α +0.02% · $263.52
- T+5 · 2mo ago −8.49%α −9.12% · $239.04
- T+20 · 6w ago −14.75%α −17.13% · $222.69
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Ascendis Pharma insiders sold a combined $873K in shares over a 7-day window, with the bulk ($811K) coming from SVP Mads Bodenhoff's open-market sale following a derivative exercise. Director Lars Holtug sold a small $62K stake. At a $17.7B market cap, the total sales represent ~0.005% of market cap, well below the 0.1% materiality threshold, making this a routine, non-informative cluster. The derivative exercise and same-day sale by Bodenhoff is a classic cashless exercise pattern, not a bearish signal.
Key Financial Metrics
Key Facts
- Two insiders sold shares totaling $873K (0.005% of $17.7B market cap)
- SVP Mads Bodenhoff exercised 3,000 options at $110, then sold the same shares at $270.19 for $811K, a routine cashless exercise
- Director Lars Holtug sold 236 shares for $62K, a trivial position reduction
- No C-suite executives (CEO/CFO) participated in the cluster
- The cluster is too small relative to market cap to carry informational content
Financial Impact
Total insider sales of $873K represent 0.005% of $17.7B market cap, immaterial
Risk Factors
- Insider sales could accelerate if stock continues to rise, but current pattern is normal liquidity-driven activity
- No bearish signal from this cluster, risk of misinterpreting routine option exercises as informed selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ASND-1789027639214 |
Track record
41 reports on ASND
14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $275.39 +1.26% settles Feb 12
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $275.39 Now $275.39 +0.00% settles Feb 11
- Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $275.39 +3.12% settles Feb 10
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $275.39 +3.12% settles Feb 10
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $275.39 +5.98% settles Feb 5
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $275.39 +7.23% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $275.39 +8.66% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $275.39 +10.08% settles Feb 1
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $275.39 +12.02% settles Jan 25
- Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $275.39 +22.26% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers